Trasylol Plaintiffs Lose Bid To Use Expert
A federal judge has refused to allow plaintiffs in the multidistrict litigation against Bayer Corp. over its blood-clotting drug Trasylol to appeal an order barring one of their proposed experts from...To view the full article, register now.
Already a subscriber? Click here to view full article